Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 183

The DOI matches its Crossref record.

Gender differences in Parkinson's disease

Shulman, Lisa M.·2007·Gender Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1550-8579(07)80003-9

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 22

  1. Dluzen, 1985, In vitro dopamine release from the rat striatum: Diurnal rhythm and its modification by the estrous cycle, Neuroendocrinology, 41, 97, 10.1159/000124160 · DOI
  2. Di Paolo, 1988, Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle, Life Sci, 43, 665, 10.1016/0024-3205(88)90137-3 · DOI
  3. Becker, 1990, Direct effect of 17 beta-estradiol on striatum: Sex differences in dopamine release, Synapse, 5, 157, 10.1002/syn.890050211 · DOI · Paper page
  4. Morissette, 1993, Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites, J Neurochem, 60, 1876, 10.1111/j.1471-4159.1993.tb13415.x · DOI
  5. McDermott, 1994, Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice, Exp Neurol, 125, 306, 10.1006/exnr.1994.1034 · DOI
  6. Becker, 1981, Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro, Brain Res, 204, 361, 10.1016/0006-8993(81)90595-3 · DOI · Paper page
  7. Dluzen, 1990, In vivo changes in responsiveness of the caudate nucleus to L-dopa infusion as a function of the estrous cycle, Brain Res, 536, 163, 10.1016/0006-8993(90)90021-3 · DOI
  8. Langston, 1999, Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyri dine exposure, Ann Neurol, 46, 598, 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F · DOI
  9. Dluzen, 1996, Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentrations and release, J Neurochem, 66, 658, 10.1046/j.1471-4159.1996.66020658.x · DOI
  10. Miller, 1998, The impact of gender and estrogen on striatal dopaminergic neurotoxicity, Ann N Y Acad Sci, 844, 153, 10.1111/j.1749-6632.1998.tb08230.x · DOI · Paper page
  11. Leranth, 2000, Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: Implications for Parkinson's disease and memory, J Neurosci, 20, 8604, 10.1523/JNEUROSCI.20-23-08604.2000 · DOI · Paper page
  12. Sawada, 2000, Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons, FASEB J, 14, 1202, 10.1096/fasebj.14.9.1202 · DOI
  13. Rajput, 1984, Epidemiology of parkinsonism: Incidence, classification, and mortality, Ann Neurol, 16, 278, 10.1002/ana.410160303 · DOI · Paper page
  14. Rocca, 2005, The Mayo clinic cohort study of oophorectomy and aging: Results for parkinsonism and Parkinson's disease, Neurology, 64, A283
  15. Marder, 1998, Postmenopausal estrogen use and Parkinson's disease with and without dementia, Neurology, 50, 1141, 10.1212/WNL.50.4.1141 · DOI
  16. Saunders-Pullman, 1999, The effect of estrogen replacement on early Parkinson's disease, Neurology, 52, 1417, 10.1212/WNL.52.7.1417 · DOI · Paper page
  17. Becker, 2002, Early diagnosis of Parkinson's disease, J Neurol, 249, /40
  18. Montgomery, 2006, Rush Limbaugh on the offensive against ad with Michael J. Fox, Washington Post, C01
  19. Kaasinen, 2001, Increased frontal [18F]fluorodopa update in early Parkinson's disease: Sex differences in the prefrontal cortex, Brain, 124, 1125, 10.1093/brain/124.6.1125 · DOI
  20. Blanchet, 1999, Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: A crossover study, Neurology, 53, 91, 10.1212/WNL.53.1.91 · DOI
  21. Tsang, 2000, Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations, Neurology, 54, 2292, 10.1212/WNL.54.12.2292 · DOI · Paper page
  22. 2006, The POETRY study: The safety, tolerability and efficacy of estrogen replacement therapy in post-menopausal women with Parkinson disease, Mov Disord, 21, 1545

Cited by

See all 183

Metadata

Authors
Shulman, L. M.
Venue
Gender Medicine
Publisher
Elsevier BV
Published
2007-03
Volume
4
Issue
1
Pages
8-18
ISSN
1550-8579 (ISSN-L)
OpenAlex
W2029879331
Cited by
183
References
0
FWCI
7.37
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gender differences in Parkinson's disease. https://app.cochat.ai/papers/10.1016/s1550-8579(07)80003-9
The paper
Shulman, L. M. (2007). Gender differences in Parkinson's disease. Gender Medicine. https://doi.org/10.1016/s1550-8579(07)80003-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.